Important Investor Alert: Levi & Korsinsky, LLP Announces Class Action Lawsuit Against Applied Therapeutics, Inc.
NEW YORK, Feb. 4, 2025
Levi & Korsinsky, LLP announces that a class action securities lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQ: APLT) common stock between January 3, 2024, and December 2, 2024. The lawsuit seeks to recover damages on behalf of those who were adversely affected by alleged securities fraud.
Class Definition
The class action lawsuit alleges that Applied Therapeutics and certain of its top executives violated the Securities Exchange Act of 1934 by making materially false and misleading statements and/or failing to disclose that:
- The Company’s lead drug candidate, AT-001, had not demonstrated consistent clinical efficacy;
- The Company had downplayed the risks associated with AT-001;
- The Company had overstated the prospects for regulatory approval of AT-001;
Implications for Individual Investors
If you invested in Applied Therapeutics, Inc. common stock between January 3, 2024, and December 2, 2024, you may be entitled to recover your losses through this class action. The lead plaintiff deadline is approaching, so it is essential that you contact Levi & Korsinsky, LLP as soon as possible. The more time we have to review the case, the greater our ability to protect your rights.
Broader Implications for the Biotech Industry
The allegations in the lawsuit against Applied Therapeutics could have significant implications for the biotech industry as a whole. In an industry where investors often place a high degree of trust in the promises of pharmaceutical companies, this lawsuit serves as a reminder of the importance of transparency and accuracy in communications with the investing public. It also underscores the need for robust regulatory oversight and rigorous clinical trial data to ensure the safety and efficacy of new drugs.
Conclusion
If you invested in Applied Therapeutics, Inc. common stock between January 3, 2024, and December 2, 2024, and wish to discuss your legal rights and potential remedies, please contact Levi & Korsinsky, LLP as soon as possible. The lead plaintiff deadline is approaching, and the more time we have to review the case, the greater our ability to protect your rights. For more information, please call us at (212) 363-7500 or contact us via email at [email protected].
Levi & Korsinsky, LLP is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, accounting fraud, and consumer protection issues. For more information, please visit
This notice is not a solicitation for class action membership. Class members are not obligated to take any action at this time to participate in the class action. If you are a class member and do nothing, you will remain an absent class member.
